glp-1 gip medications long term effects Managing GLP-1/GIP side with diet and lifestyle GLP-1 Medications: Everything You Need
Description
The drugmaker Altimmune says its new weekly injectable, pemvidutide, saw patients lose about 75% fat and only 25% muscle in results of a Phase II clinical trial the company announced on Wednesday
With this in mind, here were going to take a look at the pharmacokinetics of the two big boys (WeGovy and Mounjaro) and think about the impact those may have on the expected effects with type 1, and potentially the corroloary effects when used for other conditions
MPP+, a metabolite of MPTP, is a complex I inhibitor
No alcohol, tobacco, or substance use
